2023
Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation for Treatment of High Anisometropia in Children: Long-term Results
GRIŠČÍKOVÁ, Lenka, Rudolf AUTRATA, Inka KREJČÍŘOVÁ, Jorge L. ALIÓ, Barbora ŽAJDLÍKOVÁ et. al.Základní údaje
Originální název
Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation for Treatment of High Anisometropia in Children: Long-term Results
Autoři
GRIŠČÍKOVÁ, Lenka (703 Slovensko, garant, domácí), Rudolf AUTRATA (203 Česká republika, domácí), Inka KREJČÍŘOVÁ (203 Česká republika, domácí), Jorge L. ALIÓ, Barbora ŽAJDLÍKOVÁ (203 Česká republika, domácí), Dana TOMČÍKOVÁ (203 Česká republika) a Martin HLOŽÁNEK (203 Česká republika)
Vydání
JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, THOROFARE, SLACK INC, 2023, 0191-3913
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30207 Ophthalmology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.200 v roce 2022
Kód RIV
RIV/00216224:14110/23:00130141
Organizační jednotka
Lékařská fakulta
UT WoS
000838851100001
Klíčová slova anglicky
High Anisometropia; Children; Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 26. 1. 2024 10:35, Mgr. Tereza Miškechová
Anotace
V originále
Purpose: To evaluate the long-term efficacy of anterior chamber iris-fixated phakic intraocular lens (PIOL) implantation in the treatment of high myopic (> -9.00 diopters [D]) or hyperopic (> +6.00 D) anisometropia in children with intolerance to spectacles or contact lenses. Methods: A total of 58 children with anisometropic myopia (range: -9.25 to-18.50 diopters [D]) and 13 children with anisometropic hyperopia (range: +6.00 to +8.50 D) underwent unilateral iris-claw PIOL implantation from 2008 to 2018. The mean age was 6.7 years. The mean follow-up was 38.5 months. Target refraction was emmetropia. Results: The cycloplegic refraction (mean spherical equivalent) improved from -12.47 D (range:-9.25 to-18.50 D) to -0.73 D (range: +0.75 to -1.50 D) in myopic eyes and reduced from +7.15 D (range: +6.00 to +8.50 D) to +0.94 D (range: -0.50 to + 1.75 D) in hyperopic eyes. Eighty-four percent of eyes were corrected to within +/- 1.00 D of emmetropia. The mean uncorrected distance visual acuity (UDVA) improved from 1.74 +/- 0.36 to 0.45 +/- 0.28 logarithm of the minimum angle of resolution (logMAR) (P = .0014). The mean corrected distance visual acuity (CDVA) changed from 0.68 +/- 0.32 to 0.27 +/- 0.15 logMAR (P = .02179). The safety index was 2.18 and the efficacy index was 1.51. The mean preoperative endothelial cell count of 2,874.7 cells/mm(2) changed to 2,685.3 cells/mm(2) at 2 to 6 years postoperatively. Binocular vision quality was improved in 55 patients. No patient had serious complications or lost any Snellen lines of CDVA. Conclusions: Iris-fixated PIOL implantation is an effective and safe method in the treatment of high anisometropic myopia and hyperopia and amblyopia in pediatric patients who are noncompliant with spectacles or contact lenses.